ProShare Advisors »

Denali Therapeutics shares owned by ProShare Advisors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by ProShare Advisors from 13F filings

Historical chart of ProShare Advisors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by ProShare Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by ProShare Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $502k 24k 20.63
2023-06-30 $715k 24k 29.51
2023-03-31 $514k 22k 23.04
2022-12-31 $748k 27k 27.81
2022-09-30 $700k 23k 30.72
2022-06-30 $653k 22k 29.45
2022-03-31 $1.0M 32k 32.18
2021-12-31 $1.8M 39k 44.59
2021-09-30 $2.0M 40k 50.46
2021-06-30 $3.6M 45k 78.44
2021-03-31 $1.9M 34k 57.09
2020-12-31 $2.7M 32k 83.76
2020-09-30 $888k 25k 35.83
2020-06-30 $615k 25k 24.19
2020-03-31 $285k 16k 17.51
2019-12-31 $475k 27k 17.42
2019-09-30 $481k 31k 15.32
2019-06-30 $679k 33k 20.77
2019-03-31 $864k 37k 23.22
2018-12-31 $764k 37k 20.66